Providing clients with a flexible approach to improve cycle times, constrain costs, and reduce risks. Specialising in the planning, management, execution, and analysis of Phase 2-3 clinical trials.
1200+ global pharmacovigilance experts bring together all safety services into a seamless delivery solution.
Our professionals apply their therapeutic, regulatory, and operational expertise to consistently solve the challenges that arise during clinical projects.
Pressures such as stricter regulations, changing technologies, and globalisation stress current operational models and information infrastructure to the limits. As these pressures intensify, choosing the right model applying the right methodology to anticipate the challenges that arise during clinical trials is the only way to increase project success.
ICON guides sponsors to choose the model - traditional, decentralised or hybrid - that best addresses the clinical development challenges of the study, maximising patient recruitment and retention and at the same time expanding access to diverse patient populations. We work with you to develop strategic, flexible approaches that leverage clinical informatics, state-of-the-art technologies, and our global reach to maximise safety and efficiency and make data-driven decisions for every study.
Our functional and therapeutic expertise includes cardio-metabolic, oncology/hematology, infectious diseases, neurology/psychiatry, rare disease, respiratory, and biosimilars.
Innovative clinical trial designs that take advantage of our in-depth statistical expertise. Clinical monitoring - Agile clinical monitoring - traditional, remote or hybrid models.
Our team of dedicated clinical supplies managers ensure the most appropriate and cost-effective IP management service for your trial.
Fast delivery of high quality and meaningful data means that you can make well informed decisions earlier in the trial. This also ensures patient protection and reliable trial results.
Decentralised and hybrid clinical solutions bring the clinical trial to the patient with innovation and in-home solutions.
Endpoint Adjudication can help to lower the risk of variation in important clinical trial outcome events for submission to regulatory agencies.
Providing effective IRT solutions for patient enrolment, randomisation, dosing, and clinical supplies management.
Timely and accurate Investigator payments are critical for keeping sites motivated and driving site performance in a study.
Experienced physicians and clinical research professionals support the planning, conduct, and evaluation of clinical trials.
Medical and regulatory documentation developed by experienced medical writing teams plays a pivotal role in the success of a clinical research project.
Sound regulatory strategies are critically important in the ever evolving regulatory environment of clinical trials.
We are raising the bar in clinical excellence. By focusing on metrics that matter we are already delivering economic value to our clients. Our experience ranges from small studies to large, complex, multinational projects.
ICON’s development experts apply their expertise to make products and treatments accessible to patients through our Site & Patient Solution — whether it’s patient insight for optimised trial design, engagement with patient advocacy groups or customized patient recruitment strategies.